News | September 17, 2025
ProBioGen to spearhead GMP manufacturing at Berlin’s gene & cell therapy hub
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma
Alembic receives EIR from USFDA for facility at Panelav
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
The facility has been designed with a dual focus on efficiency and sustainability
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Subscribe To Our Newsletter & Stay Updated
